Key Points Pfizer is one of the world's best-known drug companies, offering a well-above-market dividend yield. The company is facing typical industry headwinds, which make the dividend look risky. 10 stocks we like better than Pfizer › Pfizer (NYSE: PFE) is not hitting on all cylinders today. That's why the stock is down more than 50% from its 2021 high, as of this writing, and its payout ratio is well north of 100%. Dividend investors may find the huge 6% yield attractive, but before buying, you have to ask if that dividend is actually sustainable. The answer is likely yes, here's why. Dividends don't come out of earnings The financial impact of dividends shows up on the cash flow statement, not the earnings statement.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.